.
SUMOylation promotes targeting of HP1a to pericentric heterochromatin. Here we identify the SUMO-specific protease SENP7 in mouse as a maintenance factor for HP1a accumulation at this location. SENP7 interacts directly with HP1a, localizes at HP1-enriched pericentric domains and can deconjugate SUMOylated HP1a in vivo. Depletion of SENP7 delocalizes HP1a from pericentric heterochromatin without affecting H3K9me3 levels. We propose that following targeting of HP1a, a subsequent deSUMOylation event enables HP1a retention at these domains.
HP1, a protein highly conserved throughout evolution 1,2 , interacts with many partners 2,3 that contribute to its enrichment at pericentric heterochromatin 4 . Our recent discovery that HP1α SUMOylation promotes its targeting to pericentric heterochromatin 5 in mouse cells raised the possibility that following this step, deSUMOylation could favor HP1α maintenance at these domains. SUMOylation is rapidly reversed by the action of SENPs [6] [7] [8] [9] [10] . There are six SENPs in mammals (SENP1-SENP3 and SENP5-SENP7) 8, 9 , whose exact targets are not defined 7, 9 . The presence of SENP7 in the recent list of 82 candidate interactors of the human HP1α (ref.
3) prompted us to further explore a role for this SENP as a SUMO regulator affecting HP1 stability at pericentric heterochromatin.
First, we verified that the association of SENP7 with HP1α was conserved in mouse. We found that both wild-type green fluorescent protein (GFP)-tagged mouse SENP7 (e-SENP7) and catalytically dead SENP7 C979S (e-SENP7M; ref. 11) coimmunoprecipitated with endogenous HP1α but not with KAP1 or SetDB1 (Fig. 1a and  Supplementary Fig. 1a) . We further confirmed that glutathione S-transferase (GST)-tagged SENP7 pulled down the three endogenous HP1 isoforms (Supplementary Fig. 1b) . Conversely, hemagglutinin (HA)-tagged HP1α (e-HP1α) retrieved endogenous SENP7 but not the most closely related SENP, SENP6 (Fig. 1b) , indicating that HP1α associates specifically with SENP7 regardless of its protease activity. Finally, using recombinant proteins, we determined that His-tagged SENP7 interacted directly with purified GST-HP1α (Fig. 1c) . At a cellular level, endogenous SENP7 colocalizes with HP1α at pericentric heterochromatin and remains there after extraction of soluble material with Triton, as shown by immunofluorescence experiments (Fig. 2a) . In an asynchronous cell population, 70% of the cells showed coenrichment of HP1α and SENP7 at the pericentric domain, whereas the remaining 30% of cells showed diffuse staining for both proteins (Fig. 2b) . We then investigated SENP7 localization at pericentric heterochromatin under conditions impairing localization of HP1 isoforms at these domains (after RNase A treatment on NIH3T3 cells 12 or in histone methyltransferase Suv39h double-null mouse embryonic fibroblasts 12, 13 ). Notably, both situations erased SENP7 staining at pericentric domains (Fig. 2c,d ) without affecting the total amount of SENP7 and HP1 protein. These data demonstrate that the localization of SENP7 parallels that of HP1α.
Because HP1α directly interacts with SENP7 and is modified by SUMO-1 in vivo 5 , we examined whether SENP7 could affect the levels of SUMO-1-HP1α in vivo. To obtain detectable SUMO-1-HP1 levels, we cotransfected GFP-SUMO-1 and HP1α-HA into NIH3T3 cells. Under conditions preserving SUMO modification and after immunoprecipitation of HP1α-HA, we observed a 70-kDa band corresponding to GFP-SUMO-1-HP1α-HA ( Fig. 2e and Supplementary  Figs. 2 and 3) . Notably, this band decreased in intensity upon introduction of an active GFP-SENP7 ( Fig. 2e and Supplementary  Figs. 2 and 3) , and it remained identical to control when using the catalytically dead mutant SENP7 C979S (ref. 11) expressed at levels comparable to GFP-SENP7 (Fig. 2e) . Thus, under our experimental conditions, SENP7 can deconjugate SUMO-1-modified HP1α in vivo. To further explore a functional relationship between the two proteins, we tested whether the SENP7-HP1α interaction could affect HP1α maintenance at pericentric domains. We depleted SENP7 from NIH3T3 cells by transfecting a plasmid encoding both a microRNA to downregulate SENP7 (miSENP7) and a GFP mRNA to enable identification of the transfected cells ( Fig. 3a and Supplementary Methods; see Supplementary Fig. 4a ,b for depletion efficiency). Cell viability and FACS profiles that were based on DNA staining remained comparable between control and downregulated cells ( Supplementary  Fig. 4c) . However, only 44% of GFP-positive SENP7-depleted cells showed HP1α localization at pericentric heterochromatin, compared to 70% of GFP-positive control cells (Fig. 3b,c) , indicating a significant decrease in HP1α localization at pericentric domains (P = 0.004). In these SENP7-depleted cells, HP1α showed faint staining at pericentric domains and increased diffuse nuclear staining (compare top rows of miSENP7 and control (micont) in Fig. 3b) Supplementary  Fig. 4a,b) . Notably, although SENP7 depletion led to the loss of local HP1α enrichment at pericentric heterochromatin, trimethylated histone H3 Lys9 (H3K9me3) remained present at these domains (Fig. 3d,e) , as is the case when Orc proteins are depleted 14 . We confirmed these results by siRNA depletion ( Supplementary  Fig. 4d-f) . Next, to evaluate whether this effect on HP1α was specific to SENP7, we examined SENP6, which did not colocalize with HP1α and whose depletion did not alter HP1α localization (Fig. 3f,g and Supplementary Fig. 4g ). However, we noted that SENP6 was able to deconjugate SUMOylated HP1α in the transfection assay (Supplementary Fig. 5 ). Taken together, these data underline the fact that the necessary role of SENP7 in maintaining HP1α enrichment at pericentric domains is most likely due to the specificity of SENP7 localization. That the loss of SENP7 and HP1 did not affect the H3K9me3 mark or the overall organization of the domains emphasizes the existence of distinct steps for HP1 accumulation at pericentric domains.
In conclusion, we propose that SENP7 is a newly identified maintenance factor for HP1α accumulation at pericentric heterochromatin on the basis of the following observations: (i) SENP7's direct interaction with HP1, (ii) the common behavior and localization of the two proteins at pericentric heterochromatin and (iii) loss of HP1α enrichment at pericentric heterochromatin after SENP7 depletion. Moreover, we identify SUMO-1-modified HP1α as a substrate for SENP7. Although SUMOylation is a post-translational modification involved in many cellular processes, only a few putative substrates have been identified for the SENPs 7,9 , and to our knowledge, none have been identified for SENP7. Although previous studies in vitro indicated a SENP7 deconjugating activity for SUMO-2/3 (ref. 15 ) and a limited activity for SUMO-1 (ref. 11), we provide evidence that SENP7 could equally remove SUMO-1 or SUMO-2 in vivo using exogenously expressed SUMO ( Supplementary  Fig. 6 ). Thus, given that endogenous HP1α is modified by SUMO-1, but not SUMO-2/3, when associated with major RNA, as recently detected 5 , it is tempting to consider that SENP7's role in regulating HP1α accumulation at pericentric heterochromatin could serve to remove SUMO-1. However, it is possible that SENP7 has a role in removing SUMO-2/3. To target the activity of SENP7 on SUMO-1-HP1α, the simplest options to consider are the direct interaction between SENP7 and HP1α combined with the localization of SENP7 at HP1-enriched domains. However, we do not exclude the possibility that SENP7 may deconjugate other SUMOylated factors present at pericentric domains, such as KAP1, a known HP1-interacting partner that is modified by SUMO-1 in vivo 16 .
Our data show that the cycle of SUMOylation and deSUMOylation is crucial for regulating efficient accumulation of HP1α at pericentric domains. After SUMO-dependent targeting of HP1α to pericentric heterochromatin 5 , a subsequent retention step would be promoted by SENP7 deSUMOylation activity. We find it interesting that an HP1α-SUMO-1 fusion protein that remains constitutively SUMOylated can be rapidly and efficiently targeted to pericentric heterochromatin yet proves toxic to the cells 5 . This indicates that the persistence of the SUMO modification on HP1 has deleterious consequences. Although SENP7 is likely to be the specific SUMO protease acting at these domains on modified HP1, future work should aim to identify the HP1-specific SUMO ligase machinery in order to decipher how this cycle is regulated.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
